Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Open in Screener

OCX

Oncocyte Corporation

May 17 • 04:00PM ET

2.93

Dollar change -0.14
Percentage change -4.56	%

Healthcare • Diagnostics & Research • USA • NASD

Chart Stock Detail • Compare Perf. • Revenue • Dividends • Options Options Chain • Save to Portfolio • Create Alert

Held by: VTI VXF DFSV

Index	-	P/E	-	EPS (ttm)	-25.27	Insider Own	22.97%	Shs Outstand	13.36M	Perf Week	1.38%
Market Cap	39.14M	Forward P/E	-	EPS next Y	-1.70	Insider Trans	401.84%	Shs Float	10.29M	Perf Month	14.45%
Income	-40.86M	PEG	-	EPS next Q	-0.50	Inst Own	52.57%	Short Float	3.64%	Perf Quarter	-2.33%
Sales	1.38M	P/S	28.37	EPS this Y	36.89%	Inst Trans	-23.99%	Short Ratio	5.96	Perf Half Y	-26.01%
Book/sh	1.40	P/B	2.09	EPS next Y	28.17%	ROA	-51.95%	Short Interest	0.37M	Perf Year	-44.90%
Cash/sh	0.42	P/C	7.02	EPS next 5Y	-	ROE	-132.29%	52W Range	2.08 - 5.40	Perf YTD	17.20%
Dividend Est.	-	P/FCF	-	EPS past 5Y	14.72%	ROI	-210.26%	52W High	-45.74%	Beta	0.86
Dividend TTM	-	Quick Ratio	0.78	Sales past 5Y	16.25%	Gross Margin	-60.27%	52W Low	40.87%	ATR (14)	0.18
Dividend Ex-Date	-	Current Ratio	0.78	EPS Y/Y TTM	-92.98%	Oper. Margin	-1580.32%	RSI (14)	57.60	Volatility	7.64% 6.52%
Employees	46	Debt/Eq	0.20	Sales Y/Y TTM	-	Profit Margin	-2956.66%	Recom	1.67	Target Price	4.42
Option/Short	No / Yes	LT Debt/Eq	0.15	EPS Q/Q	-380.86%	Payout	-	Rel Volume	0.50	Prev Close	3.07
Sales Surprise	-49.71%	EPS Surprise	7.81%	Sales Q/Q	-40.74%	Earnings	May 15 AMC	Avg Volume	62.73K	Price	2.93
SMA20	9.01%	SMA50	3.68%	SMA200	-5.44%	Trades		Volume	31,516	Change	-4.56%

Date	Action	Analyst	Rating Change	Price Target Change
May-24-22	Downgrade	Stephens	Overweight → Equal-Weight
Mar-14-22	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
Jan-07-22	Initiated	Stephens	Overweight	$3.10
Jan-06-22	Resumed	Piper Sandler	Overweight	$3.10
Mar-17-21	Resumed	Needham	Buy	$8
Jan-07-21	Upgrade	The Benchmark Company	Speculative Buy → Buy	$6
Dec-16-20	Upgrade	Piper Sandler	Neutral → Overweight	$2 → $4
Nov-30-20	Initiated	BTIG Research	Buy	$5
Nov-10-20	Initiated	KeyBanc Capital Markets	Overweight	$5
Jul-30-20	Reiterated	The Benchmark Company	Speculative Buy	$7 → $6
Jul-01-20	Downgrade	Piper Sandler	Overweight → Neutral
Jun-30-20	Downgrade	Chardan Capital Markets	Buy → Neutral	$2
Jun-02-20	Initiated	Needham	Buy	$4
Feb-13-19	Initiated	Piper Jaffray	Overweight	$6
Jan-29-19	Upgrade	Janney	Neutral → Buy
Dec-19-18	Resumed	Lake Street	Buy

Show Previous Ratings

May-15-24 08:55PM	OCX Stock Earnings: OncoCyte Misses EPS, Misses Revenue for Q1 2024 (InvestorPlace)
04:05PM	Oncocyte Reports First Quarter 2024 Financial Results (GlobeNewswire)
May-13-24 08:00AM	Oncocyte to Announce First Quarter 2024 Financial Results (GlobeNewswire)
May-07-24 09:19AM	PRISM MarketView Spotlights Oncocyte Corporation as it Works to Disrupt the Precision Diagnostics Marketplace (GlobeNewswire)
Apr-12-24 10:52AM	OCX Stock Earnings: OncoCyte Misses EPS, Misses Revenue for Q4 2023 (InvestorPlace) -8.60%
06:00AM	Loading…
06:00AM	Oncocyte Reports Full Year 2023 Financial Results (GlobeNewswire)
Apr-11-24 09:46PM	Oncocyte Corporation Announces $15.8 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules (GlobeNewswire)
05:30PM	Oncocyte and Bio-Rad Partner on Global Launch of Transplant Assay (GlobeNewswire)
Apr-09-24 04:05PM	Oncocyte to Announce Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
Jan-16-24 08:00AM	Oncocyte to Present at the Sequire Investor Summit in Puerto Rico (GlobeNewswire)
Dec-06-23 08:00AM	Oncocyte Begins FDA Submissions Process for VitaGraft Transplant Assays (GlobeNewswire)
Nov-09-23 08:27AM	OncoCyte Corp (OCX) Reports Q3 2023 Financial Results with Key Product Launches on the Horizon (GuruFocus.com) +29.71%
07:00AM	Oncocyte Reports Third Quarter 2023 Financial Results (GlobeNewswire)
Nov-03-23 08:30AM	Oncocyte to Announce Third Quarter 2023 Financial Results (GlobeNewswire) +8.09%
Sep-18-23 08:00AM	Oncocyte's VitaGraftTM Kidney Identifies Transplant Rejection 10 Months Earlier (ACCESSWIRE) +5.49%
08:00AM	Loading…
Sep-06-23 08:00AM	Oncocyte to Participate in the H.C. Wainwright 25th Annual Global Investment Conference (ACCESSWIRE)
Aug-28-23 08:30AM	Oncocyte's VitaGraft Kidney Transplant Diagnostic Test Receives CMS Coverage (ACCESSWIRE)
Aug-10-23 07:00AM	Oncocyte Reports Second Quarter 2023 Financial Results (ACCESSWIRE)
Aug-09-23 08:00AM	Oncocyte Regains Compliance With Nasdaq Listing Requirements (ACCESSWIRE)
Aug-08-23 08:30AM	Oncocyte to Participate in 8th Annual Needham Virtual MedTech & Diagnostics 1×1 Conference (ACCESSWIRE) -5.29%
Aug-03-23 08:00AM	Oncocyte To Announce Second Quarter 2023 Financial Results (ACCESSWIRE)
Jul-25-23 09:08AM	VitaGraft Kidney Expands Utility in Recurrent Primary Disease Patients (GlobeNewswire)
Jul-24-23 01:35PM	Oncocyte Announces 1-For-20 Reverse Stock Split (GlobeNewswire) -9.57%
Jun-27-23 08:30AM	Oncocyte Begins Manufacturing Transplant Blood Test (GlobeNewswire)
Jun-01-23 04:15PM	Oncocyte Corporation to Present at the LD Micro Invitational XIII (Newsfile) +6.55%
May-11-23 08:00AM	Oncocyte Reports First Quarter 2023 Financial Results (GlobeNewswire)
Apr-27-23 04:59PM	Oncocyte To Announce First Quarter 2023 Financial Results (GlobeNewswire) +9.86%
Apr-18-23 08:45AM	Oncocyte Presents New Data at AACR (GlobeNewswire)
Apr-12-23 04:15PM	Oncocyte Announces Reduction in Force (GlobeNewswire)
Apr-07-23 08:24AM	Oncocyte Announces Publication of DetermaIO Results from AtezoTRIBE Study in Metastatic Colorectal Cancer (GlobeNewswire)
08:00AM	Loading…
Apr-03-23 08:00AM	Oncocyte Pricing of $13.86 Million Public Offering of Common Stock (GlobeNewswire) -10.41%
Mar-31-23 05:00PM	Oncocyte Reports Preliminary Fourth Quarter and Full Year 2022 Financial Results and Plans to File Form 12b-25 to Extend Filing Date of Its Form 10-K (GlobeNewswire) +26.57%
Mar-29-23 04:01PM	Oncocyte Announces Date Change for Fourth Quarter and Full Year 2022 Earnings Call (GlobeNewswire) +5.52%
Mar-15-23 04:01PM	Oncocyte to Announce Fourth Quarter and Full Year 2022 Financial Results (GlobeNewswire) -20.00%
Mar-02-23 09:00AM	Oncocyte Appoints Joshua Riggs as President and Chief Executive Officer (GlobeNewswire)
Feb-22-23 08:00AM	Oncocyte Completes Razor Genomics Transaction (GlobeNewswire)
Dec-16-22 08:19AM	Oncocyte cuts 40% of staff (MarketWatch) -21.95%
08:00AM	Oncocyte Announces Initiatives to Focus Corporate Strategy (GlobeNewswire)
Nov-30-22 06:05PM	Oncocyte Announces the Appointment of Louis E. Silverman as a Member of Its Board of Directors (GlobeNewswire)
06:00PM	Oncocyte Announces Executive Leadership Changes (GlobeNewswire)
Nov-10-22 04:30PM	Oncocyte Reports Third Quarter 2022 Financial Results (GlobeNewswire)
Oct-27-22 04:01PM	Oncocyte to Announce Third Quarter 2022 Financial Results (GlobeNewswire) -13.50%
Oct-06-22 08:00AM	DetermaIO Clinical Test to be used in SWOG Cancer Research Network Biomarker Study for Breast Cancer (GlobeNewswire)
Sep-07-22 08:00AM	Oncocyte Announces Unanimous Recommendation from the Advisory Panel for Clinical Diagnostic Laboratory Tests on DetermaRx to CMS (GlobeNewswire)
Aug-31-22 04:01PM	Oncocyte to Participate at the Lake Street 6th Annual Best Ideas Growth Conference (GlobeNewswire)
Aug-30-22 04:27PM	Oncocyte Announces Five-Year VA Contract for DetermaRx (GlobeNewswire) -6.93%
Aug-24-22 08:00AM	Oncocyte Announces Publication of the Validation of DetermaIO in Predicting Immune Therapy Response in Metastatic Bladder Cancer (GlobeNewswire)
Aug-10-22 04:05PM	Oncocyte Reports Second Quarter 2022 Financial Results (GlobeNewswire) +10.57%
Aug-03-22 04:01PM	Oncocyte to Participate at Upcoming Investor Conferences (GlobeNewswire)
Aug-01-22 11:33AM	The past year for OncoCyte (NASDAQ:OCX) investors has not been profitable (Simply Wall St.)
05:00AM	Oncocyte Announces the Appointment of John Peter Gutfreund as Independent Member of Its Board of Directors Effective July 28, 2022 (GlobeNewswire)
Jul-27-22 04:01PM	Oncocyte to Announce Second Quarter 2022 Financial Results (GlobeNewswire)
Jul-13-22 08:00AM	Oncocyte Announces Market Entry and Early Adopter Program for Transplant Rejection Monitoring Business (GlobeNewswire) +5.75%
Jul-06-22 08:00AM	Oncocyte Presents DetermaIO Data in Podium Presentation at ESMO World Congress on Gastrointestinal Cancer 2022 (GlobeNewswire)
Jun-22-22 08:00AM	Oncocyte Hosting Key Opinion Webinar on the Role of DetermaIO and the Tumor Microenvironment in Clinical Practice (GlobeNewswire)
Jun-15-22 07:15AM	How Much Of OncoCyte Corporation (NASDAQ:OCX) Do Insiders Own? (Simply Wall St.)
May-26-22 05:00PM	Oncocyte Presents DetermaIO Data at ASCO 2022 Supporting the Tests Potential to Expand the Clinical Use of Immunotherapy (GlobeNewswire)
May-11-22 04:05PM	Oncocyte Reports First Quarter 2022 Financial Results (GlobeNewswire)
May-05-22 08:00AM	Oncocyte Completes Validation of TheraSure Transplant Monitor Test (GlobeNewswire)
Apr-28-22 04:01PM	Oncocyte to Announce First Quarter 2022 Financial Results (GlobeNewswire)
Apr-27-22 04:30PM	Oncocyte to Present New Data at ASCO 2022 Underpinning Pan-Cancer Clinical Utility of DetermaIO (GlobeNewswire)
Apr-22-22 09:26AM	A number of insiders bought OncoCyte Corporation (NASDAQ:OCX) stock last year, which is great news for shareholders (Simply Wall St.)
Apr-13-22 10:01PM	Oncocyte Corporation Announces Pricing of Public Offering of Common Stock and Warrants (GlobeNewswire)
05:12PM	Oncocyte Corporation Announces Proposed Public Offering of Common Stock and Warrants (GlobeNewswire)
05:10PM	Oncocyte Corporation Announces Pricing of Registered Direct Offering of 11,765 Shares of Series A Convertible Preferred Stock (GlobeNewswire)
Apr-11-22 08:00AM	Oncocyte Presents Confirmatory Data for DetermaIO at the American Association for Cancer Research Annual Meeting 2022 (GlobeNewswire)
Mar-28-22 08:00AM	Oncocyte to Present New Data Confirming Association of IO Score with Response to Immunotherapy Treatment for Bladder Cancer at the American Association for Cancer Research Annual Meeting 2022 (GlobeNewswire)
Mar-10-22 04:05PM	Oncocyte Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update (GlobeNewswire) +7.69%
Mar-01-22 04:05PM	Oncocyte to Report Fourth Quarter and Full Year 2021 Financial Results on Thursday March 10 (GlobeNewswire)
Feb-21-22 07:26AM	Shareholders in OncoCyte (NASDAQ:OCX) have lost 78%, as stock drops 12% this past week (Simply Wall St.)
Feb-10-22 08:00AM	Oncocyte to Present at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference (GlobeNewswire)
Jan-18-22 04:05PM	Oncocyte Announces Development and Co-Marketing Agreement with Thermo Fisher Scientific to Expand Access to Precision Oncology (GlobeNewswire) +15.87%
Jan-06-22 09:43AM	What Type Of Shareholders Make Up OncoCyte Corporation's (NASDAQ:OCX) Share Registry? (Simply Wall St.)
Jan-04-22 08:00AM	Oncocyte Announces Peer-Reviewed Publication in Cancers Showing Utility of DetermaCNI Blood-Only Monitoring Test to Detect Recurrence Following Surgery in Epithelial Ovarian Cancer (GlobeNewswire)
Dec-09-21 06:00PM	Spotlight Poster Presentation at San Antonio Breast Cancer Symposium SABCS 2021 Shows Oncocytes DetermaIO Clinical Test Predicts Response to Immunotherapy in Triple Negative Breast Cancer (GlobeNewswire) -9.81%
Dec-08-21 08:00AM	Oncocyte and Burning Rock Complete Technology Transfer Part Two and Prepare for Scaled Distribution of DetermaRx in China (GlobeNewswire) +10.42%
Dec-06-21 08:00AM	Oncocyte Corporation Hosting Business Update Call (GlobeNewswire)
Dec-02-21 08:00AM	Oncocyte to Present New Data on DetermaIO Clinical Test for Immunotherapy Response in Triple Negative Breast Cancer at San Antonio Breast Cancer Symposium 2021 (GlobeNewswire)
Nov-22-21 06:14AM	Is OncoCyte (NASDAQ:OCX) Using Too Much Debt? (Simply Wall St.) -5.43%
Nov-09-21 04:05PM	Oncocyte Reports Third Quarter 2021 Financial Results and Provides Corporate Update (GlobeNewswire)
Nov-04-21 08:00AM	Oncocyte Announces the Clinical Launch of DetermaIO Immunotherapy Response Prediction Test (GlobeNewswire)
Nov-02-21 03:02PM	Will OncoCyte (OCX) Report Negative Earnings Next Week? What You Should Know (Zacks)
Oct-27-21 08:00AM	Oncocyte Strengthens Transplant Intellectual Property Portfolio with US Patent Covering Digital PCR Technology for Early Detection of Organ Transplant Rejection (GlobeNewswire) -5.00%
Oct-26-21 04:05PM	Oncocyte to Report Third Quarter 2021 Financial Results on Tuesday, November 9th (GlobeNewswire)
Oct-08-21 09:46AM	A OncoCyte Corporation (NASDAQ:OCX) insider increased their holdings by 11% last year (Simply Wall St.)
Oct-07-21 08:00AM	Oncocyte Appoints Gisela A. Paulsen as Chief Operating Officer (GlobeNewswire)
Sep-30-21 08:00AM	Oncocyte Publishes Study Demonstrating Predictive Potential for DetermaIO® Test in Triple Negative Breast Cancer (GlobeNewswire)
Sep-20-21 11:35AM	Oncocyte Announces Oral Presentation of New Data on Its DetermaIO Immunotherapy Response Test at the European Society for Medical Oncology Annual Meeting (GlobeNewswire)
08:00AM	Oncocyte Hosting Two-Part Key Opinion Leader Event Series (GlobeNewswire)
Sep-16-21 08:00AM	Modern Healthcare Recognizes Oncocyte as One of the 2021 Best Places to Work in Healthcare (GlobeNewswire)
Sep-13-21 08:00AM	Oncocyte to Present New Data on DetermaIO from NeoTRIPaPDL1 Trial in Oral Presentation from Late-Breaking Abstract at ESMO 2021 (GlobeNewswire)
Sep-07-21 04:05PM	Oncocyte to Participate in the 5th Annual Lake Street Capital Markets Best Ideas Growth Conference (GlobeNewswire)
Aug-23-21 09:13AM	Investors in OncoCyte (NASDAQ:OCX) have made a strong return of 202% over the past year (Simply Wall St.)
Aug-18-21 08:49AM	Is the Options Market Predicting a Spike in OncoCyte (OCX) Stock? (Zacks)
Aug-17-21 08:00AM	Oncocyte Launches First Real-World Evidence (RWE) Registry to Evaluate Biomarker Impact on Early-Stage Lung Cancer Treatment Decisions and Outcomes (GlobeNewswire)
Aug-10-21 04:01PM	Oncocyte Reports Second Quarter 2021 Financial Results and Provides Corporate Update (GlobeNewswire)
Aug-09-21 08:00AM	Oncocyte to Participate in Upcoming Investor Events (GlobeNewswire)
Aug-03-21 03:00PM	Will OncoCyte (OCX) Report Negative Earnings Next Week? What You Should Know (Zacks)
Jul-27-21 10:35AM	Oncocyte to Report Second Quarter 2021 Financial Results on Tuesday, August 10 (GlobeNewswire)
Jul-08-21 05:34AM	Here's What OncoCyte Corporation's (NASDAQ:OCX) Shareholder Ownership Structure Looks Like (Simply Wall St.)

OncoCyte Corp. is a molecular diagnostics company, which engages in the development and commercialization of diagnostic tests for the detection of cancer, including molecular diagnostic services to pharmaceutical customers. Its products include DetermaRx and DetermaIO. The firm also offers pharmaceutical services like multi-analyte test development and clinical trial services. The company was founded in September 2009 and is headquartered in Alameda, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
BROADWOOD PARTNERS, L.P.	10% Owner	Apr 11 '24	Buy	2.92	2,420,000	7,057,688	4,929,066	Apr 15 07:21 PM
Arno Andrew	Director	Apr 11 '24	Buy	2.95	33,898	99,999	69,054	Apr 15 06:02 AM
Riggs Josh	CEO and President	Apr 11 '24	Buy	2.95	3,390	10,000	3,505	Apr 15 06:04 AM
KINGSLEY ALFRED D	Director	Jun 14 '23	Buy	0.21	30,000	6,447	469,111	Jun 15 08:13 PM

Open in Screener

XXII

22nd Century Group Inc

May 17 • 04:00PM ET

1.39

Dollar change -0.13
Percentage change -8.55	%

Consumer Defensive • Tobacco • USA • NASD

Chart Stock Detail • Compare Perf. • Revenue • Dividends • Options Options Chain • Save to Portfolio • Create Alert

Held by: VXF MJ

Index	-	P/E	-	EPS (ttm)	-102.71	Insider Own	0.00%	Shs Outstand	7.90M	Perf Week	-9.15%
Market Cap	10.98M	Forward P/E	-	EPS next Y	-15.20	Insider Trans	-	Shs Float	7.90M	Perf Month	-18.71%
Income	-141.91M	PEG	-	EPS next Q	-4.96	Inst Own	6.43%	Short Float	1.14%	Perf Quarter	-44.63%
Sales	55.06M	P/S	0.20	EPS this Y	82.97%	Inst Trans	-	Short Ratio	0.06	Perf Half Y	-75.53%
Book/sh	-3.23	P/B	-	EPS next Y	23.39%	ROA	-162.38%	Short Interest	0.09M	Perf Year	-99.05%
Cash/sh	0.45	P/C	3.12	EPS next 5Y	-	ROE	-346.39%	52W Range	1.45 - 170.40	Perf YTD	-53.34%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-49.91%	ROI	-	52W High	-99.18%	Beta	1.51
Dividend TTM	-	Quick Ratio	0.43	Sales past 5Y	5.41%	Gross Margin	-27.11%	52W Low	-4.14%	ATR (14)	0.18
Dividend Ex-Date	-	Current Ratio	0.54	EPS Y/Y TTM	-28.96%	Oper. Margin	-127.59%	RSI (14)	37.51	Volatility	6.89% 8.74%
Employees	64	Debt/Eq	-	Sales Y/Y TTM	-26.61%	Profit Margin	-257.72%	Recom	2.00	Target Price	53.28
Option/Short	No / Yes	LT Debt/Eq	-	EPS Q/Q	85.43%	Payout	-	Rel Volume	0.27	Prev Close	1.52
Sales Surprise	-17.67%	EPS Surprise	67.42%	Sales Q/Q	-70.54%	Earnings	May 15 BMO	Avg Volume	1.53M	Price	1.39
SMA20	-15.51%	SMA50	-25.11%	SMA200	-84.51%	Trades		Volume	411,451	Change	-8.55%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-21-22	Initiated	Alliance Global Partners	Buy	$5
Jun-15-22	Initiated	Craig Hallum	Buy	$5
Mar-08-22	Initiated	ROTH Capital	Buy	$6
Jul-23-21	Initiated	Cowen	Outperform	$5
Oct-16-17	Reiterated	Chardan Capital Markets	Buy	$3.50 → $11.50
Aug-11-16	Reiterated	Chardan Capital Markets	Buy	$4.50 → $3.50

May-15-24 10:52AM	XXII Stock Earnings: 22nd Century Group Beats EPS, Misses Revenue for Q1 2024 (InvestorPlace)
06:00AM	22nd Century Group Reports First Quarter 2024 Financial Results (Newsfile)
May-13-24 08:00AM	22nd Century Eliminates an Additional $2.3 Million of Debt (Newsfile)
May-08-24 09:18AM	22nd Century Group to Participate in the Aegis Capital Virtual Conference on May 9, 2024 (Newsfile)
May-07-24 08:15AM	22nd Century Group (XXII) to Announce First Quarter 2024 Results on May 15, 2024 (Newsfile)
09:00AM	Loading…
Apr-30-24 09:00AM	22nd Century Eliminates $5.2 Million of Debt in Above-Market Equity Transaction (Newsfile) -5.95%
Apr-29-24 09:00AM	Keynotes, Educational Panels and 96 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 30 - May 2, 2024 at the Paris Hotel & Casino in Las Vegas, NV (ACCESSWIRE)
Apr-18-24 05:00PM	22nd Century Group Announces Resignation of Sullivan and Mish from the Board of Directors (Newsfile)
09:00AM	22nd Century Group Regains Compliance with NASDAQ Minimum Bid Price Rule (Newsfile)
Apr-15-24 09:00AM	22nd Century Group to Participate in the Planet MicroCap Showcase on May 1-2, 2024 (Newsfile)
Apr-11-24 04:45PM	22nd Century Group Expands CMO Business with New Pinnacle Brand Cigarillo Products (Newsfile)
Apr-08-24 09:25AM	22nd Century Announces Plan to Eliminate Its Senior Secured Debt (Newsfile) -40.17%
09:01AM	Why Is 22nd Century (XXII) Stock Down 33% Today? (InvestorPlace)
Apr-05-24 02:52PM	Why Is 22nd Century Group (XXII) Stock Up 100% Today? (InvestorPlace) +140.54%
Apr-04-24 05:48PM	22nd Century Group (XXII) Signs Large New CMO Customer (Newsfile) -16.38%
02:59PM	Loading…
Apr-01-24 02:59PM	22nd Century Group, Inc. (NASDAQ:XXII) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-28-24 12:53PM	XXII Stock Earnings: 22nd Century Group Misses EPS, Misses Revenue for Q4 2023 (InvestorPlace) -8.75%
06:00AM	22nd Century Group (XXII) Reports Fourth Quarter 2023 Financial Results (Newsfile)
Mar-15-24 08:00AM	22nd Century Group to Announce Fourth Quarter 2023 Results on March 28, 2024 (Newsfile) -7.30%
Feb-13-24 04:15PM	22nd Century Group Announces Reduction in Board Compensation (Newsfile)
Feb-07-24 07:00AM	Presenting on the Emerging Growth Conference 67 Day 2 on February 8 Register Now (GlobeNewswire) -9.74%
Feb-06-24 11:00AM	22nd Century Group to Present at the Emerging Growth Conference on February 8, 2024 (Newsfile) -11.43%
Feb-05-24 07:29AM	22nd Century Group CEO Larry Firestone: Transforming Tobacco Industry with FDA-Approved VLN Brand (News Direct)
Jan-24-24 04:15PM	22nd Century Group Announces Partial Adjournment of Annual Meeting for Proposal 2, All Other Proposals Passed (Newsfile)
Jan-17-24 08:45AM	22nd Century Group Provides Shareholder Update and Highlights Insider Stock Purchases from Management (Newsfile) -16.72%
Jan-12-24 08:30AM	22nd Century Group to Host Fireside Chat Event on January 17 (Newsfile)
Dec-28-23 04:20PM	22nd Century Group Completes Sale of Hemp/Cannabis Franchise (Newsfile)
Dec-14-23 04:05PM	22nd Century Group's Senior Lender Approves Sale of Hemp/Cannabis Franchise on Improved Terms (Newsfile)
Dec-04-23 07:07AM	22nd Century Secures $3.2 Million to Date in Warrant Exchange Transaction (GlobeNewswire) -12.26%
Nov-29-23 07:07AM	22nd Century Appoints Larry Firestone as Chairman and CEO (GlobeNewswire) +39.26%
04:44PM	Loading…
Nov-27-23 04:44PM	22nd Century Group Enters into Agreement to Sell Hemp/Cannabis Franchise (GlobeNewswire) -6.26%
Nov-08-23 01:15PM	22nd Century Group Continues VLN Expansion, Now Retailing in More Than 5,100 Stores (GlobeNewswire) -8.41%
Nov-07-23 08:45AM	22nd Century Group (XXII) Expands Reduced Nicotine Content Tobacco IP with Latest Technology License (GlobeNewswire)
Nov-06-23 08:16AM	22nd Century Group Inc (XXII) Reports Q3 2023 Financial Results: Net Loss Widens Amid Expansion ... (GuruFocus.com) -10.89%
07:30AM	22nd Century Group (XXII) Reports Third Quarter 2023 Financial Results (GlobeNewswire)
Oct-29-23 05:17PM	Weekly Roundup on the Cannabis Sector & Psychedelic Sector (Market Exclusive)
Oct-26-23 08:30AM	22nd Century Group (XXII) Supports FDA Policy Advancements, Proposed Menthol Ban Now at OMB (GlobeNewswire)
Oct-25-23 09:00AM	22nd Century Group (XXII) Reduces Debt by $8.1 Million (GlobeNewswire)
Oct-17-23 09:15AM	22nd Century Announces Pricing of $5.25 Million Public Offering (GlobeNewswire)
Oct-16-23 04:05PM	22nd Century Announces Proposed Public Offering (GlobeNewswire) -6.79%
Sep-12-23 07:00AM	22nd Century Group (XXII) Adds 1,200 Drug Store Locations Selling VLN® in Five States (GlobeNewswire) +13.60%
Sep-05-23 07:00AM	Presenting on the Emerging Growth Conference on September 6 and 7 Register Now (GlobeNewswire) +22.22%
07:00AM	22nd Century Group Initiates Strategic Alternatives Process for Its Tobacco Assets (GlobeNewswire)
Aug-17-23 09:39AM	Adobe upgraded, BorgWarner downgraded: Wall Street's top analyst calls (The Fly)
Aug-14-23 06:00AM	22nd Century Group (XXII) Reports Second Quarter 2023 Financial Results (GlobeNewswire) -16.73%
Aug-09-23 08:00AM	22nd Century Group (XXII) Updates Second Quarter 2023 Results Webcast Time on August 14, 2023 (GlobeNewswire) -5.41%
Aug-08-23 07:00AM	Presenting on the Emerging Growth Conference on August 9 & 10 Register Now (GlobeNewswire)
Aug-07-23 08:00AM	22nd Century Group (Nasdaq: XXII) to Announce Second Quarter 2023 Results on August 14, 2023 (GlobeNewswire) -6.33%
Jul-31-23 08:57AM	Weekly Roundup on the Cannabis Sector & Psychedelic Sector (Market Exclusive)
Jul-24-23 10:47AM	New to The Street TV Announces Episode 491 with its Five Business Guest Interviews, Airs on FOX Business Network, Tonight, July 24, 2023, at 10:30 PM PT (GlobeNewswire) -35.57%
09:20AM	22nd Century Announces Executive Leadership Changes (GlobeNewswire)
Jul-20-23 09:20AM	22nd Century Group (XXII) Regains Compliance with Nasdaq Listing Standards (GlobeNewswire) +35.04%
Jul-17-23 09:20AM	A Cigarette to Help Californians Smoke Less: 22nd Century Group, Inc. Launches Reduced Nicotine VLN® King Cigarettes in California, VLN Will Be Sold at #1 U.S. Convenience Store Chain and Other Responsible Retail Locations (GlobeNewswire)
Jul-13-23 09:40AM	New to The Street TV Announces Episode 488 with its Five Business Guest Interviews, Airs as Sponsored Programming on Bloomberg TV, Tonight, July 13, 2023, at 9:30 PM PT (GlobeNewswire) +8.89%
08:40AM	22nd Century Group (XXII) VLN® Products Now Selling in Montana C-Stores (GlobeNewswire)
Jul-12-23 08:35AM	22nd Century Group (XXII) Announces New Agreement with Hub, Inc. to Expand Midwest Distribution (GlobeNewswire) -5.86%
Jul-06-23 09:25AM	22nd Century Announces $3.0 Million Registered Direct Offering Priced Above Market (GlobeNewswire) -28.19%
Jul-03-23 06:00AM	22nd Century Announces 1-for-15 Reverse Stock Split (GlobeNewswire) -22.13%
Jun-23-23 09:00AM	22nd Century Group (XXII) Announces Production of VLN® Homogenized Tobacco Leaf Sheet (GlobeNewswire) -6.45%
Jun-21-23 09:00AM	VLN® Products Launch in Nevada to Help Smokers Smoke Less (GlobeNewswire)
Jun-20-23 07:00AM	22nd Century Announces $5.3 Million Registered Direct Offering Priced Above Market (GlobeNewswire)
Jun-06-23 09:00AM	22nd Century Group (XXII) Launching VLN® at #1 U.S. C-Store Chain in Texas, California and Florida (GlobeNewswire) +9.37%
Jun-02-23 08:30AM	22nd Century Group (XXII) Announces Participation in the LD Micro Invitational XIII (GlobeNewswire)
May-25-23 09:00AM	22nd Century Group (XXII) Highlights Recent TCORS Symposium Findings (GlobeNewswire) -8.04%
May-09-23 06:00AM	22nd Century Group (Nasdaq: XXII) Reports First Quarter 2023 Financial Results, Introduces 2023 Full Year Revenue Outlook (GlobeNewswire)
May-03-23 09:15AM	22nd Century Group (Nasdaq: XXII) to Announce First Quarter 2023 Results on May 9, 2023 (GlobeNewswire)
May-02-23 09:15AM	22nd Century Group (XXII) Announces Strategic License, Manufacturing and Distribution Agreement with Old Pal (GlobeNewswire) +5.38%
Apr-18-23 07:00AM	22nd Century Group Launches New Private Label Brand with Top U.S. C-Store Chain (Newsfile)
Apr-05-23 08:30AM	22nd Century Group (XXII) Announces Fully Integrated, Single-Source Strategic License, Manufacturing and Distribution Agreement with Cookies (GlobeNewswire)
Mar-09-23 06:00AM	22nd Century Group (Nasdaq: XXII) Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update (GlobeNewswire)
Mar-03-23 04:05PM	22nd Century Group (XXII) Secures $21 Million Debt Financing to Expand Working Capital for Growth Initiatives (GlobeNewswire) +6.71%
Mar-02-23 04:15PM	22nd Century Group (Nasdaq: XXII) to Participate in March 2023 Roth Investor Conference (GlobeNewswire)
Feb-23-23 09:00AM	22nd Century Group (Nasdaq: XXII) to Announce Fourth Quarter and Full Year 2022 Results on March 9, 2023 (GlobeNewswire)
Feb-22-23 09:00AM	22nd Century Group (XXII) Accelerates Major Growing Program to Enable Implementation of New Zealands Reduced-Nicotine Content Tobacco Law (GlobeNewswire)
Feb-07-23 09:00AM	Nearly Three Out of Four Colorado Smokers Want to Quit and Now Have a New Option That Helps You Smoke Less (GlobeNewswire)
Jan-24-23 09:20AM	22nd Century Group (XXII) Acquires RX Pharmatech Ltd, Greatly Strengthening UK and EU Market Position (GlobeNewswire)
Jan-23-23 09:33PM	Weekly Roundup on the Cannabis Sector & Psychedelic Sector (Market Exclusive)
09:20AM	22nd Century Group (XXII) Announces Filing of U.S. DMF (Drug Master File) for CBD API; New Global Sales, Marketing and Distribution Agreement with Transo-Pharm for Cannabinoid APIs (GlobeNewswire)
Jan-18-23 09:25AM	22nd Century Group (XXII) Announces U.S. Distribution Partnerships with Core-Mark and Eby-Brown (Newsfile)
Jan-17-23 09:00AM	FDA's Proposed Menthol Ban Advances to Final Rule Status, Greatly Benefits 22nd Century (XXII) by Affirming the Need for VLN(R) Menthol King as a Critical Off-Ramp for Adult Menthol Smokers (Newsfile) +6.48%
Dec-16-22 08:05AM	In a New Audio Interview, Toni Loudenbeck of Traders News Source Interviews John Miller President, 22nd Century Group Inc. (ACCESSWIRE)
Dec-13-22 09:25AM	22nd Century Group (XXII) Comments on the Advancement of New Zealand's National Reduced Nicotine Content Law (Newsfile)
Dec-08-22 01:00PM	22nd Century Group Provides Update on Grass Valley Facility (Newsfile)
Nov-21-22 04:10PM	22nd Century Group Provides Update on Incident at Grass Valley Facility (Newsfile) -14.52%
Nov-17-22 06:00AM	22nd Century Group had a big year. The FDA could make 2023 even bigger. (American City Business Journals) +5.69%
Nov-16-22 09:25AM	22nd Century Groups GVB Biopharma Opens New Central Distribution Facility in The Netherlands (GlobeNewswire)
Nov-15-22 09:25AM	22nd Century Group (Nasdaq: XXII) GVB Biopharma to Exhibit at MJBizCon in Las Vegas (GlobeNewswire)
Nov-14-22 08:19AM	22nd Century Group (Nasdaq: XXII) to Participate in November 2022 Investor Conferences (GlobeNewswire) +5.04%
Nov-08-22 06:00AM	22nd Century Group (Nasdaq: XXII) Reports Business Highlights and Financial Results for the Third Quarter 2022 (GlobeNewswire) -18.12%
Nov-07-22 09:43AM	New Study Again Shows 22nd Centurys Reduced Nicotine Content Cigarettes Reduce Cigarette Consumption and Increase Smoking Cessation (GlobeNewswire) +8.66%
Oct-27-22 09:15AM	22nd Century Group (Nasdaq: XXII) to Announce Third Quarter 2022 Results on November 8, 2022 (GlobeNewswire)
Oct-26-22 09:25AM	22nd Century Group (Nasdaq: XXII) to Expand VLN® Sales in Three Additional States: Arizona, Utah and New Mexico (GlobeNewswire)
Oct-18-22 09:20AM	22nd Century Group (Nasdaq: XXII) to Present at LD Micro Conference on October 26 (GlobeNewswire)
Oct-06-22 04:05PM	22nd Century Group (Nasdaq: XXII) to Participate in the Dawson James Small Cap Growth Conference on October 12 (GlobeNewswire)
09:30AM	First Cigarette Authorized by FDA to Help You Smoke Less Now Available Across Colorado (GlobeNewswire)
Oct-03-22 09:25AM	22nd Century Group (Nasdaq: XXII) Expands VLN® Distributor Network with the Addition of Specialty Distributor Creager Mercantile (GlobeNewswire)
Sep-20-22 09:25AM	22nd Century Group (Nasdaq: XXII) Partners With Eagle Rock Distributing Company to Place VLN® in Thousands of Retail Locations Across Colorado (GlobeNewswire) -13.56%
Sep-13-22 09:30AM	22nd Century Groups (Nasdaq: XXII) VLN® Cigarettes with Reduced Nicotine Technology Ready to Ignite Bidens Cancer Moonshot Initiative (GlobeNewswire)
Sep-12-22 04:05PM	22nd Century Group (Nasdaq: XXII) Appoints Accomplished Media Executive Lucille S. Salhany to Its Board (GlobeNewswire)
Sep-07-22 04:45PM	22nd Century Group (Nasdaq: XXII) Announces Management Updates and Departure of Chief Operating Officer (GlobeNewswire) +6.56%

22nd Century Group, Inc. is a biotechnology company, which engages in the business of tobacco harm reduction, reduced nicotine tobacco, and improvement of health and wellness through plant science. It operates through the Tobacco and Hemp/Cannabis segments. The Tobacco segment manufactures branded filtered cigars and cigarettes. The Hemp/Cannabis segment focuses on the bulk ingredient distillate or isolate. The company was founded on September 12, 2005 and is headquartered in Buffalo, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Arno Andrew	Director	Jan 05 '24	Buy	0.17	100,000	17,490	100,000	Jan 08 08:04 PM
FIRESTONE LAWRENCE	Chief Executive Officer	Jan 04 '24	Buy	0.17	100,000	17,360	100,000	Jan 05 04:32 PM

Open in Screener

SMSI

Smith Micro Software, Inc.

May 17 • 04:00PM ET

2.72

Dollar change +0.04
Percentage change 1.30	%

Technology • Software - Application • USA • NASD

Chart Stock Detail • Compare Perf. • Revenue • Dividends • Options Options Chain • Save to Portfolio • Create Alert

Held by: VTI VXF IWC

Index	-	P/E	-	EPS (ttm)	-5.35	Insider Own	10.77%	Shs Outstand	9.35M	Perf Week	4.62%
Market Cap	26.11M	Forward P/E	2.27	EPS next Y	1.20	Insider Trans	-4.63%	Shs Float	8.57M	Perf Month	22.25%
Income	-48.52M	PEG	-	EPS next Q	-0.24	Inst Own	11.22%	Short Float	5.12%	Perf Quarter	-58.06%
Sales	35.73M	P/S	0.73	EPS this Y	25.00%	Inst Trans	-56.32%	Short Ratio	2.44	Perf Half Y	-57.92%
Book/sh	4.73	P/B	0.57	EPS next Y	350.00%	ROA	-63.13%	Short Interest	0.44M	Perf Year	-73.02%
Cash/sh	0.64	P/C	4.24	EPS next 5Y	10.75%	ROE	-81.32%	52W Range	1.88 - 14.96	Perf YTD	-58.84%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-21.69%	ROI	-101.77%	52W High	-81.82%	Beta	0.77
Dividend TTM	-	Quick Ratio	1.70	Sales past 5Y	12.88%	Gross Margin	52.89%	52W Low	44.50%	ATR (14)	0.26
Dividend Ex-Date	-	Current Ratio	1.70	EPS Y/Y TTM	-30.54%	Oper. Margin	-51.56%	RSI (14)	56.85	Volatility	8.06% 10.26%
Employees	231	Debt/Eq	0.08	Sales Y/Y TTM	-23.50%	Profit Margin	-135.79%	Recom	1.00	Target Price	14.67
Option/Short	Yes / Yes	LT Debt/Eq	0.05	EPS Q/Q	-266.48%	Payout	-	Rel Volume	0.76	Prev Close	2.68
Sales Surprise	1.07%	EPS Surprise	-87.50%	Sales Q/Q	-46.95%	Earnings	May 08 AMC	Avg Volume	179.45K	Price	2.72
SMA20	13.00%	SMA50	7.77%	SMA200	-58.86%	Trades		Volume	137,098	Change	1.30%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-29-22	Initiated	The Benchmark Company	Buy	$5
Aug-05-21	Initiated	Dawson James	Buy	$11.10
Apr-27-21	Initiated	The Benchmark Company	Buy	$9
Oct-19-20	Initiated	Lake Street	Buy	$7
Jul-19-19	Initiated	B. Riley FBR	Buy	$5
Oct-19-15	Downgrade	Needham	Buy → Hold
Feb-25-15	Upgrade	Needham	Hold → Buy	$2.10
Jan-07-15	Upgrade	H.C. Wainwright	Neutral → Buy	$2
Jul-18-14	Initiated	H.C. Wainwright	Neutral
May-05-11	Downgrade	Needham	Buy → Hold
Apr-20-11	Downgrade	Wedbush	Outperform → Neutral	$12 → $9
Feb-09-11	Downgrade	Northland Securities	Outperform → Market Perform	$17 → $10
Feb-09-11	Downgrade	Brigantine	Buy → Hold
Jan-25-11	Initiated	Dougherty & Company	Neutral	$12
Dec-10-10	Reiterated	Wedbush	Outperform	$16 → $19
Nov-12-10	Reiterated	Northland Securities	Outperform	$15 → $17
Nov-10-10	Initiated	Brigantine	Buy	$18
Nov-04-10	Reiterated	Wedbush	Outperform	$13 → $16
Nov-04-10	Reiterated	Northland Securities	Outperform	$13 → $15
May-12-10	Upgrade	Wedbush	Neutral → Outperform	$11 → $12.50

Show Previous Ratings

May-14-24 04:05PM	Smith Micro Announces Closing of Follow-on Offering (Business Wire)
May-13-24 09:23AM	Smith Micro (SMSI) Unveils Marketing Programs for SafePath (Zacks)
May-10-24 08:15AM	Smith Micro Announces Follow-on Offering (Business Wire) +11.11%
May-09-24 01:43PM	Smith Micro Software, Inc. (NASDAQ:SMSI) Q1 2024 Earnings Call Transcript (Insider Monkey)
08:41AM	Smith Micro's (SMSI) Q1 Earnings Miss, Revenues Down Y/Y (Zacks)
09:56PM	Loading…
May-08-24 09:56PM	SMSI Stock Earnings: Smith Micro Software Misses EPS, Beats Revenue for Q1 2024 (InvestorPlace)
07:24PM	Smith Micro Reports First Quarter 2024 Financial Results (Business Wire)
04:05PM	Smith Micro Introduces New Affiliate Influencer and Retail Ambassador Marketing Programs for Promotion of its SafePath-Based Solutions (Business Wire)
May-01-24 04:56PM	Smith Micro Schedules Teleconference to Announce First Quarter 2024 Financial Results (Business Wire)
Apr-30-24 11:56AM	SMSI Stock Earnings: Smith Micro Software Meets EPS, Misses Revenue for Q2 2023 (InvestorPlace) -6.85%
09:15AM	Smith Micro Regains Compliance with Nasdaq Minimum Bid Price Requirement (Business Wire)
Apr-05-24 11:51AM	Smith Micro Software's (SMSI) SafePath Solution Gains Traction (Zacks)
Apr-03-24 04:15PM	Smith Micro Announces 1-for-8 Reverse Stock Split (Business Wire)
Apr-02-24 07:00AM	Smith Micro Announces New Agreement with a Mobile Operator in the US for Deployment of Its SafePath Platform (Business Wire) +6.85%
Feb-23-24 10:23AM	Smith Micro Software, Inc. (NASDAQ:SMSI) Q4 2023 Earnings Call Transcript (Insider Monkey) -40.51%
06:52AM	Loading…
06:52AM	Q4 2023 Smith Micro Software Inc Earnings Call (Thomson Reuters StreetEvents)
Feb-22-24 04:10PM	Smith Micro Reports Fourth Quarter and Fiscal Year 2023 Financial Results (Business Wire)
04:05PM	Smith Micro Announces New SafePath OS Solution Expanding its Focus on Family Safety (Business Wire)
Feb-15-24 04:15PM	Smith Micro Schedules Teleconference to Announce Fourth Quarter and Fiscal Year 2023 Financial Results (Business Wire)
Jan-30-24 03:15PM	7 Tech Penny Stocks for Explosive Growth at Bargain Prices (InvestorPlace) +5.95%
Jan-11-24 09:15AM	Smith Micro Retires Senior Secured Convertible Notes (Business Wire)
Dec-05-23 09:15AM	Leading Tier 1 European Mobile Operator Signs New SafePath Multiyear Contract with Smith Micro (Business Wire) +15.10%
Nov-09-23 10:40AM	Smith Micro Software, Inc. (NASDAQ:SMSI) Q3 2023 Earnings Call Transcript (Insider Monkey) -29.25%
09:17AM	Q3 2023 Smith Micro Software Inc Earnings Call (Thomson Reuters StreetEvents)
Nov-08-23 04:05PM	Smith Micro Reports Third Quarter and Year-to-Date 2023 Financial Results (Business Wire)
Nov-07-23 09:15AM	Smith Micro Announces New Enhanced Solutions to SafePath Platform for 2024 (Business Wire)
Oct-31-23 04:05PM	Smith Micro Schedules Teleconference to Announce Third Quarter and Year-to-Date 2023 Financial Results (Business Wire)
Oct-20-23 12:28PM	Magic Software (MGIC) Stock Jumps 6.2%: Will It Continue to Soar? (Zacks)
Sep-17-23 10:54AM	15 Penny Stocks with Biggest Upside (Insider Monkey)
Aug-30-23 09:15AM	U.S. Tier 1 Carrier Launches Upgraded Family Security Application Powered by Smith Micros SafePath® Platform (Business Wire) +6.10%
06:15PM	Loading…
Aug-09-23 06:15PM	Smith Micro Software, Inc. (SMSI) Reports Q2 Loss, Misses Revenue Estimates (Zacks) +7.76%
04:05PM	Smith Micro Reports Second Quarter and Year-to-Date 2023 Financial Results (Business Wire)
Aug-01-23 04:05PM	Smith Micro Schedules Teleconference to Announce Second Quarter and Year-to-Date 2023 Financial Results (Business Wire)
Jul-13-23 11:42AM	AudioEye (AEYE) Unveils Enterprise-Level Digital Accessibility (Zacks) +6.19%
Jul-11-23 09:56AM	The past three years for Smith Micro Software (NASDAQ:SMSI) investors has not been profitable (Simply Wall St.)
May-11-23 05:55PM	Smith Micro Software, Inc. (SMSI) Reports Q1 Loss, Tops Revenue Estimates (Zacks) -6.72%
04:05PM	Smith Micro Reports First Quarter 2023 Financial Results (Business Wire)
May-04-23 09:15AM	Smith Micro Schedules Teleconference to Announce First Quarter 2023 Financial Results (Business Wire)
Apr-28-23 09:15AM	Smith Micro to Speak at Mobile Carriers Show Presented by Competitive Carriers Association (CCA) (Business Wire)
Mar-29-23 09:15AM	Smith Micro Executes Previously Announced Cost Reduction Plans (Business Wire) +7.00%
Mar-15-23 03:18AM	OptimizeRx Corp. (OPRX) Soars 7.2%: Is Further Upside Left in the Stock? (Zacks) -8.77%
Mar-13-23 02:55AM	Smith Micro Software, Inc. (NASDAQ:SMSI) Q4 2022 Earnings Call Transcript (Insider Monkey)
Mar-10-23 06:53AM	Smith Micro Software (SMSI) Q4 Earnings in Line With Estimates (Zacks) -10.45%
05:59AM	Q4 2022 Smith Micro Software Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-09-23 06:35PM	Smith Micro Software, Inc. (SMSI) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Smith Micro Reports Fourth Quarter and Fiscal Year 2022 Financial Results (Business Wire)
Mar-06-23 09:35AM	Smith Micro Software, Inc. (SMSI) Loses -56.36% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner (Zacks)
Mar-02-23 04:05PM	Smith Micro Schedules Teleconference to Announce Fourth Quarter and Fiscal Year 2022 Financial Results (Business Wire)
Mar-01-23 04:21PM	Smith Micro Expands Data and Analytics Capabilities of ViewSpot® Retail Display Management Platform (Business Wire)
Feb-27-23 01:02PM	Why Smith Micro Software Shares Are Plunging Today (Benzinga) -36.40%
09:15AM	Smith Micro Today Announces Notice of Termination from Tier 1 Carrier for the Companys Family Safety Solution (Business Wire)
Feb-21-23 09:15AM	Smith Micro to Attend MWC Barcelona Exploring and Accelerating New Growth Initiatives (Business Wire)
Feb-12-23 04:17PM	10 Most Undervalued Cloud Stocks Under $10 According To Hedge Funds (Insider Monkey)
Feb-01-23 08:12AM	Investors in Smith Micro Software (NASDAQ:SMSI) have made a respectable return of 57% over the past five years (Simply Wall St.)
Jan-17-23 09:15AM	Smith Micro Executes New Digital Family Safety Contract with Tier 1 U.S. Mobile Network Operator (Business Wire) +7.29%
Nov-29-22 09:15AM	Smith Micro Celebrates 40 Years of Delivering Software Solutions to the Telecommunications Industry (Business Wire)
Nov-28-22 09:15AM	Smith Micro to Present at the Benchmark Companys Upcoming Discovery One-on-One Investor Conference (Business Wire) -5.07%
Nov-12-22 07:18AM	Smith Micro Software Third Quarter 2022 Earnings: EPS Misses Expectations (Simply Wall St.)
Nov-09-22 08:51PM	CORRECTING and REPLACING Smith Micro Reports Third Quarter 2022 Financial Results (Business Wire) -6.33%
07:45PM	Smith Micro Software, Inc. (SMSI) Reports Q3 Loss, Misses Revenue Estimates (Zacks)
04:47PM	Smith Micro Reports Third Quarter 2022 Financial Results (Business Wire)
Nov-02-22 04:05PM	Smith Micro Schedules Teleconference to Announce Third Quarter 2022 Financial Results (Business Wire) -6.28%
Aug-12-22 11:27AM	10 Penny Stocks for Long-Term Profits (Insider Monkey) -23.03%
02:31AM	Smith Micro Software (SMSI) Q2 2022 Earnings Call Transcript (Motley Fool)
Aug-11-22 06:15PM	Smith Micro Software, Inc. (SMSI) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Smith Micro Reports Second Quarter 2022 Financial Results (Business Wire)
04:05PM	Smith Micro Announces Note and Common Stock Investments (Business Wire)
01:27PM	Top Penny Stocks for August 2022 (Investopedia)
06:31AM	Smith Micro Software (NASDAQ:SMSI) shareholders have earned a 23% CAGR over the last five years (Simply Wall St.)
Aug-04-22 04:05PM	Smith Micro Schedules Teleconference to Discuss Second Quarter 2022 Financial Results (Business Wire)
Jul-19-22 09:19AM	Top 10 Multibagger Penny Stocks to Buy in 2022 (Insider Monkey) +5.18%
Jun-13-22 06:27AM	Calculating The Intrinsic Value Of Smith Micro Software, Inc. (NASDAQ:SMSI) (Simply Wall St.) -6.57%
Jun-10-22 10:23AM	15 Best Penny Stocks To Invest In (Insider Monkey)
May-11-22 01:35PM	Why Smith Micro Software, Inc. (NASDAQ:SMSI) Could Be Worth Watching (Simply Wall St.)
May-04-22 09:30PM	Smith Micro Software (SMSI) Q1 2022 Earnings Call Transcript (Motley Fool)
05:25PM	Smith Micro Software, Inc. (SMSI) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:01PM	Smith Micro Welcomes Sales Leader Von Cameron as Chief Revenue Officer (Business Wire)
04:01PM	Smith Micro Reports First Quarter 2022 Financial Results (Business Wire)
May-02-22 04:05PM	Baudax Bio to Report First Quarter 2022 Financial Results and Host Conference Call and Webcast on May 5, 2022 (GlobeNewswire)
Apr-27-22 04:05PM	Smith Micro Schedules Teleconference to Discuss First Quarter 2022 Financial Results (Business Wire)
Apr-25-22 05:35PM	Cadence Design Systems (CDNS) Surpasses Q1 Earnings and Revenue Estimates (Zacks)
Apr-12-22 08:30AM	Smith Micro Appoints New Members to the Board of Directors (Business Wire)
Apr-05-22 08:30AM	Smith Micro Announces $7.0 Million Revolving Credit Facility (Business Wire)
Mar-30-22 09:31AM	Smith Micro Announces First Deployment of SafePath® 7 Technology (Business Wire)
Mar-10-22 10:00PM	Smith Micro Software (SMSI) Q4 2021 Earnings Call Transcript (Motley Fool)
04:12PM	Smith Micro Reports Fourth Quarter and Fiscal Year 2021 Financial Results (Business Wire)
Mar-04-22 05:35AM	Investors in Smith Micro Software (NASDAQ:SMSI) have made a strong return of 183% over the past five years (Simply Wall St.)
Mar-03-22 04:40PM	Smith Micro Schedules Teleconference to Discuss Fourth Quarter and Fiscal Year 2021 Financial Results (Business Wire)
Mar-02-22 06:15PM	Descartes Systems (DSGX) Q4 Earnings Match Estimates (Zacks)
Feb-23-22 06:05PM	Ansys (ANSS) Beats Q4 Earnings and Revenue Estimates (Zacks)
Feb-07-22 08:38PM	NorthRock Partners, LLC Buys PepsiCo Inc, iShares MSCI EAFE ETF, iShares MSCI Emerging Markets ... (GuruFocus.com)
Dec-09-21 12:15AM	Smith Micro Software Inc (SMSI) President & CEO William W Jr Smith Sold $586,300 of Shares (GuruFocus.com)
Nov-11-21 12:00PM	Smith Micro Software (SMSI) Q3 2021 Earnings Call Transcript (Motley Fool)
Nov-10-21 04:05PM	Smith Micro Reports Third Quarter 2021 Financial Results (Business Wire)
Nov-05-21 02:24PM	What Percentage Of Smith Micro Software, Inc. (NASDAQ:SMSI) Shares Do Insiders Own? (Simply Wall St.)
Oct-27-21 03:03PM	Earnings Preview: Smith Micro Software, Inc. (SMSI) Q3 Earnings Expected to Decline (Zacks)
08:00AM	Smith Micro Schedules Teleconference to Discuss Third Quarter 2021 Financial Results (Business Wire)
Oct-06-21 08:00AM	Smith Micro Appoints James Kempton as New Chief Financial Officer (Business Wire)
Sep-29-21 08:00AM	Smith Micro Survey Finds that Parents Rely on a Myriad of Technology to Protect their Kids Online (Business Wire)
Sep-28-21 05:11AM	Strength Seen in Smith Micro Software, Inc. (SMSI): Can Its 7.7% Jump Turn into More Strength? (Zacks) -5.44%

Smith Micro Software, Inc. engages in the provision of software solutions. It offers wireless internet solutions which enable access to information and entertainment. Its products include SafePath Family, SafePath IoT, SafePath Home, CommSuite VVM, CommSuite VTT, and ViewSpot. The company was founded by William W. Smith Jr. on November 30, 1982 and is headquartered in Pittsburgh, PA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
SMITH WILLIAM W JR	President & CEO	Mar 13 '24	Sale	0.35	11,651	4,078	673,262	Mar 15 04:33 PM
Kempton James M	VP, CFO and Treasurer	Mar 13 '24	Sale	0.35	4,804	1,681	407,973	Mar 15 04:34 PM
SMITH WILLIAM W JR	President & CEO	Jan 23 '24	Sale	0.77	6,952	5,319	353,559	Jan 24 04:34 PM
Kempton James M	VP, CFO and Treasurer	Jan 23 '24	Sale	0.77	2,293	1,754	234,664	Jan 24 04:36 PM
SMITH WILLIAM W JR	President & CEO	Dec 01 '23	Sale	0.67	17,660	11,832	439,168	Dec 01 06:11 PM
Kempton James M	VP, CFO and Treasurer	Dec 01 '23	Sale	0.67	6,780	4,543	238,830	Dec 01 06:09 PM
Kempton James M	VP, CFO and Treasurer	Jun 14 '23	Buy	1.19	1,000	1,190	204,719	Jun 15 04:58 PM

affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings

OCX

Oncocyte Corporation

XXII

22nd Century Group Inc

SMSI

Smith Micro Software, Inc.

Upgrade your FINVIZ experience